09/04/2026
Modular Medical, Inc. (NASDAQ: MODD) has received FDA clearance for software enhancements to its Pivot™ tubeless insulin patch pump, arriving ahead of its planned fourth quarter commercial launch.
The updates give users greater flexibility in bolus dosing, an enhanced user interface, and the ability to customize insulin delivery with each button push.
"The cleared improvements represent the first in a series of enhancements to the Pivot platform," said CEO Jeb Besser. "We're proud of the team's performance in obtaining this clearance and look forward to bringing these capabilities to customers."
Learn more: https://ir.modular-medical.com/press-release-details.php?newsId=beae1c58-7e93-41e3-af61-1a4be2ac64d0